Foghorn Therapeutics Inc.
FHTX
$4.47
-$0.115-2.51%
| Weiss Ratings | FHTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | FHTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | FHTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.88 | |||
| Price History | FHTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.71% | |||
| 30-Day Total Return | 12.19% | |||
| 60-Day Total Return | -22.75% | |||
| 90-Day Total Return | -44.47% | |||
| Year to Date Total Return | -2.72% | |||
| 1-Year Total Return | -33.95% | |||
| 2-Year Total Return | -14.30% | |||
| 3-Year Total Return | -58.31% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -55.32% | |||
| 52-Week Low % Change | 18.65% | |||
| Price | FHTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $10.25 | |||
| 52-Week Low Price | $3.86 | |||
| 52-Week Low Price (Date) | Jan 29, 2025 | |||
| 52-Week High Price (Date) | Sep 18, 2024 | |||
| Valuation | FHTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 254.70M | |||
| Enterprise Value | 48.09M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.65 | |||
| Earnings Per Share Growth | -29.65% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 12.74 | |||
| Price/Book (Q) | -5.59 | |||
| Enterprise Value/Revenue (TTM) | 2.13 | |||
| Price | $4.47 | |||
| Enterprise Value/EBITDA (TTM) | -0.49 | |||
| Enterprise Value/EBIT | -0.48 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | FHTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 62.87M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | FHTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 617 586 3100 | |||
| Address | 500 Technology Square Cambridge, MA 02139 | |||
| Website | foghorntx.com | |||
| Country | United States | |||
| Year Founded | 2015 | |||
| Profitability | FHTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -443.69% | |||
| Profit Margin | -383.24% | |||
| Management Effectiveness | FHTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -22.00% | |||
| Return on Equity | -- | |||
| Income Statement | FHTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 22.60M | |||
| Total Revenue (TTM) | 22.60M | |||
| Revenue Per Share | $0.36 | |||
| Gross Profit (TTM) | -94.79M | |||
| EBITDA (TTM) | -97.17M | |||
| EBIT (TTM) | -100.29M | |||
| Net Income (TTM) | -86.62M | |||
| Net Income Avl. to Common (TTM) | -86.62M | |||
| Total Revenue Growth (Q YOY) | -50.49% | |||
| Earnings Growth (Q YOY) | 19.09% | |||
| EPS Diluted (TTM) | -1.65 | |||
| EPS Diluted Growth (Q YOY) | 45.66% | |||
| Balance Sheet | FHTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 243.75M | |||
| Cash Per Share (Q) | $3.88 | |||
| Total Current Assets (Q) | 249.60M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -45.53M | |||
| Current Ratio (Q) | 3.726 | |||
| Book Value Per Share (Q) | -$0.82 | |||
| Total Assets (Q) | 283.98M | |||
| Total Current Liabilities (Q) | 66.99M | |||
| Total Debt (Q) | 37.13M | |||
| Total Liabilities (Q) | 329.51M | |||
| Total Common Equity (Q) | -45.53M | |||
| Cash Flow | FHTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -29.90M | |||
| Cash from Financing (TTM) | 105.43M | |||
| Net Change in Cash (TTM) | -24.88M | |||
| Levered Free Cash Flow (TTM) | -40.30M | |||
| Cash from Operations (TTM) | -100.41M | |||
